Nateglinide
These highlights do not include all the information needed to use NATEGLINIDE TABLETS safely and effectively. See full prescribing information for NATEGLINIDE TABLETS. NATEGLINIDE tablets, for oral use Initial U.S. Approval: 2000
c678b772-acba-4b59-a0b2-d70d84283425
HUMAN PRESCRIPTION DRUG LABEL
Dec 28, 2022
Cadila Pharmaceuticals Limited
DUNS: 862257719
Products 2
Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.
Nateglinide
Product Details
FDA regulatory identification and product classification information
FDA Identifiers
Product Classification
Product Specifications
INGREDIENTS (14)
Nateglinide
Product Details
FDA regulatory identification and product classification information